Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Insulin Resistance 1Endocrine System Diseases 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 35Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × adrenosterone × Clear all
NCT05263557 2023-07-25

DIMOXIS

Royal College of Surgeons, Ireland

Phase NA Unknown
20 enrolled

Endocrine System Diseases, Insulin Resistance, Polycystic Ovary Syndrome

NCT05246865 2022-11-02

11OXO-PCOS

University of Birmingham

Phase NA Unknown
100 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡